ABSTRACT
OBJECTIVE: To perform a systematic review of the literature on bacterial resistance, tolerance and susceptibility of silver within the context of wound therapy using silver-based dressings. METHODS: A literature search was carried out using PubMed, Embase and Cochrane Library databases, the focus was whether results from microbiological experimental in vitro tests with reference strains and clinical wound isolates are reflected in clinical practice with regards to their 'resistance' profiles, comparable with those observed for antibiotics. The search results were allocated to six categories: resistance and resistance mechanism, in vitro tests with standard strains and wound isolates, prevalence and incidence, impact on clinical practice and impact on antibiotic therapy as well as reviews, expert opinions and consensus. RESULTS: Based on all findings of the literature, it cannot be confirmed that a related clinical resistance to silver-ions in silver-based dressings has clinical impact, although endogenous and exogenous genetic resistance patterns have been described and intensively investigated. A translation of these genetic resistance-expression structures to phenotypic appearances, similar to those known for antibiotics, has not been demonstrated for silver in the literature. CONCLUSION: It can be concluded that there is no definitive evidence available and further studies should be conducted.
Subject(s)
Anti-Infective Agents/therapeutic use , Silver/therapeutic use , Surgical Wound Infection/drug therapy , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Bandages , Drug Resistance, Bacterial/drug effects , Humans , Silver/administration & dosage , Silver/pharmacology , Surgical Wound Infection/microbiologyABSTRACT
HINTERGRUND: Da die wissenschaftliche Evidenz für Silber in der Wundbehandlung meist als unzureichend angesehen wird, besteht für die Anwender eine Unsicherheit hinsichtlich des klinischen Einsatzes. MATERIAL UND METHODIK: Von einer Expertengruppe wurden die publizierten klinischen Studien zu Silber in der Wundbehandlung für den Zeitraum 2000-2015 ausgewertet. ERGEBNISSE: Es konnten 851 Artikel identifiziert werden, von denen 173 Artikel eingeschlossen und kategorisiert wurden. Hierbei fanden sich 31 randomisierte kontrollierte Studien (RCTs) und acht Kohortenstudien. Bei 28 dieser Studien fanden sich statistisch signifikante Endparameter zugunsten von Silber. Thematisch waren dies neun Studien zu Verbrennungen, 20 Studien zu anderen Indikationen (9 x Ulcus cruris venosum, 3 x Dekubitus, 2 x chronische Wunde, 1 x diabetisches Fußsyndrom und 5 x andere Wunden), 16 Studien mit dem Parameter Heilung, zwölf Studien bezogen sich auf Lebensqualität inklusive Schmerz, acht Studien mit Kosteneffektivität und drei Studien mit Reduktion der bakteriellen Keimlast. Auf der Basis dieser Ergebnisse wurde ein Behandlungsalgorithmus für Silber in der Wundbehandlung entwickelt. SCHLUSSFOLGERUNGEN: Diese aktuelle Metaanalyse zeigt, dass die Evidenzlage für Silber in der Wundbehandlung deutlich besser ist, als in der derzeitigen wissenschaftlichen Diskussion wahrgenommen wird. So ergeben sich bei gezieltem und zeitlich begrenztem Einsatz neben den antimikrobiellen Effekten unter anderem auch Hinweise auf eine Verbesserung der Lebensqualität sowie eine gute Kosteneffektivität.
ABSTRACT
BACKGROUND: Given that the scientific evidence for silver in wound care is generally considered insufficient, there is uncertainty among users regarding its clinical use. MATERIAL AND METHODS: A group of experts evaluated the clinical studies on silver in wound management published from 2000-2015. RESULTS: Overall, 851 articles were identified, 173 of which were included and categorized. There were 31 randomized controlled trials (RCTs) and eight cohort studies. Twenty-eight of these studies showed statistically significant outcome parameters in support of silver. While nine of these studies investigated burn injuries, 20 addressed other indications (venous leg ulcers: 9; pressure ulcers: 3; chronic wounds: 2; diabetic foot ulcer: 1; other types of wounds: 5). In 16 studies, the primary parameter was wound healing, whereas quality of life including pain was assessed in twelve studies; cost-effectiveness, in eight studies; reduction of bacterial load, in three studies. Based on these results, a treatment algorithm for the clinical use of silver in wound care has been developed. CONCLUSIONS: The present meta-analysis shows that the evidence base for silver in wound management is significantly better than perceived in the current scientific debate. Thus, if used selectively and for a limited period of time, silver not only has antimicrobial effects but is also characterized by an improvement in quality of life and good cost-effectiveness.
Subject(s)
Burns/drug therapy , Burns/epidemiology , Lacerations/drug therapy , Lacerations/epidemiology , Silver/therapeutic use , Wound Healing/drug effects , Evidence-Based Medicine , Humans , Prevalence , Treatment OutcomeABSTRACT
BACKGROUND: Orthopedic implant infections represent a serious complication for both patient and surgeon. In order to minimize this risk, it has become standard practice in surgery and orthopedics to add antimicrobial substances to the polymethylmethacrylate (PMMA) bone cement. The aim of this study is to find new options for preventing infection by using alternative adjuvants in combination with PMMA. We hypothesized, that Octenidine, after being combined with PMMA, can be released in vitro and an antimicrobial efficacy of discharged Octenidine can be shown. METHODS: The release of Octenidine from PMMA was assessed in high pressure liquid chromatography of the supernatant. In order to assess the efficacy of Octenidine on Staphylococcus aureus and Pseudomonas aeruginosa in vitro, a nutrient solution for these bacteria was incubated with a defined number of these bacteria (10(6) colony forming units) and cement pellets containing the antiseptic Octenidine for 24 h. After the incubation the number of bacteria in the solution was determined by counting the colony forming units on blood agar plates. RESULTS: Octenidine was shown to be released in a concentration-dependent manner from PMMA in the elution experiment. The experimental procedure using S. aureus demonstrated a bactericidal effect for bone cement containing Octenidine. For P. aeruginosa, bone cement containing 5-8% Octenidine was associated with tenfold reduction in bacterial count. CONCLUSION: These results suggest that Octenidine is released after combining it with PMMA and reaches working concentrations in vitro. These findings suggest a new and effective alternative for prevention of infection in cemented implants. Further investigations on the biocompatibility of this combination is needed.
